Amphastar Pharmaceuticals, Inc.

AMPH · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.0B · 1,976 employees
173
SEC Filings
$18.41
Close 2026-05-22
1,976
Employees

Business Summary

. Overview We are a biopharmaceutical company focusing on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as active pharmaceutical ingredient, or API products. We currently manufacture and sell over 25 prescription pharmaceutical products, and an over-the-counter product, Primatene MIST . Our largest products by net revenues currently include BAQSIMI glucagon nasal powder, or BAQSIMI , Primate...

Latest Stock Quote

AMPH 2026-05-22 $18.41 O:$18.25 H:$18.44 L:$17.93 Vol:0.5M VWAP:$18.2032
origin leaf: 7cb25cc1d5eb41503b93f683eeab805905338a221ea29943e8e3da9f1f61875c

Next Earnings

Q2 FY2026 — expected 2026-09-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001297184-26-000009EDGAR102K words
2025-03-032024-12-310001297184-25-000008EDGAR—
2024-02-292023-12-310001297184-24-000009EDGAR—
2023-03-012022-12-310001297184-23-000019EDGAR—
2022-03-112021-12-310001297184-22-000007EDGAR—
2021-03-152020-12-310001297184-21-000008EDGAR—
2020-03-162019-12-310001297184-20-000007EDGAR—
2019-03-152018-12-310001297184-19-000013EDGAR—
2018-03-142017-12-310001297184-18-000011EDGAR—
2017-03-152016-12-310001297184-17-000007EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001297184-25-000064EDGAR33K words
2025-08-072025-06-300001297184-25-000050EDGAR—
2025-05-082025-03-310001297184-25-000029EDGAR—
2024-11-072024-09-300001297184-24-000058EDGAR—
2024-08-092024-06-300001297184-24-000048EDGAR—
2024-05-102024-03-310001297184-24-000037EDGAR—
2023-11-082023-09-300001297184-23-000082EDGAR—
2023-08-092023-06-300001297184-23-000066EDGAR—
2023-05-092023-03-310001297184-23-000049EDGAR—
2022-11-082022-09-300001297184-22-000056EDGAR—
2022-08-092022-06-300001297184-22-000044EDGAR—
2022-05-102022-03-310001297184-22-000029EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-160001104659-26-027814EDGAR1K words
2026-03-060001297184-26-000015EDGAR—
2026-03-060001297184-26-000013EDGAR—
2026-02-260001297184-26-000007EDGAR—
2026-01-120001297184-26-000002EDGAR—
2025-11-060001297184-25-000062EDGAR—
2025-10-240001297184-25-000058EDGAR—
2025-09-180001297184-25-000054EDGAR—
2025-08-120001558370-25-011134EDGAR—
2025-08-070001297184-25-000048EDGAR—

173 total filings indexed. 141 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001297184
TickerAMPH
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
Websitehttps://www.amphastar.com
Listed2014-06-25

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: eae2c9113130a147f8c46365f4bd8d9574f08afa43a5607f17a345d73317bc4c
parent: 03cfc0c3de2619c1c038ca8d91ac2bc118cdddd266b440a7d7a4a6d7ed9e79ee
content hash: d07718b0d2943f5bf44f4afe5377a8f4ea2027803983508b55dfa9b47dcac2f0
signed: 2026-06-02T19:00:11.301Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf